Clinical Use of Curcumin in Depression: A Meta-Analysis
Ng QX, Koh SSH, Chan HW, Ho CYX
Published in Journal of the American Medical Directors Association
Methodology
Meta-analysis of six randomized controlled trials of curcumin supplementation for depressive symptoms in adults with major depression or depressive symptoms.
Key Findings
Curcumin significantly reduced depression severity versus placebo, with a moderate standardised mean difference and a smaller reduction in anxiety symptoms.
Conclusions
Curcumin appears to reduce depressive symptoms and is well tolerated, but the trials are small.
Limitations
Few, small trials with heterogeneous formulations and short durations; possible publication bias.
Supplements Studied
Curcumin significantly reduced depression severity versus placebo, with a smaller reduction in anxiety symptoms.
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Academic (no external funding declared)
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.